chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: TDAP
Symptoms: Expired product administered, Exposure during pregnancy, No adverse event
Clinical narrative: patient received a dose of ADACEL that was later found to have been expired with no adverse event; pregnant, at 28 weeks gestation with no reported adverse event; Initial information was received on 22-Apr-2022 regarding an unsolicited valid  non-serious case received from other health professional.  This case involves a 34years old female patient who was exposed to vaccine Diphtheria-2/Tetanus/5 AC Pertussis Vaccine [Adacel] in context of patient received a dose of Adacel that was later found to have been expired with no adverse event and pregnant, at 28 weeks gestation with no reported adverse event.   Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported patient received a dose of ADACEL that was later found to have been expired with no adverse event, pregnant and at 28 weeks gestation with no reported adverse event occurred at 28 weeks of pregnancy.  The date of last menstrual period, estimated due date were not reported.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  The patient had unknown previous pregnancy/ies.  Concomitant medications included COVID-19 Vaccine (COVID-19 Vaccine) for Immunisation.  On 21-Apr-2022, the patient received 0.5 ml dose of suspect Diphtheria-2/Tetanus/5 AC Pertussis Vaccine (batch/lot number: U6539AA) via intramuscular route in the left deltoid (strength, formulation, expiration date: unknown) for immunization.   On 21-Apr-2022, the patient received a dose of adacel that was later found to have been expired with no adverse event (expired product administered) and pregnant, at 28 weeks gestation with no reported adverse event (exposure during pregnancy) (latency: same day) following the administration of Diphtheria-2/Tetanus/5 AC Pertussis Vaccine.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for both the events (expired product administered and exposure during pregnancy).  Additionally, at time of reporting, the outcome of the pregnancy is unknown.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: MNQ
Symptoms: Expired product administered, Medication error, No adverse event
Clinical narrative: was given expired dose of Menactra on 22APR2022, with no reported adverse event; Initial information received on 25-Apr-2022 regarding an unsolicited valid non-serious case received via pharmacist.  This case involves an unknown age and unknown gender patient who experienced was given expired dose of menactra on 22apr2022, with no reported adverse event while receiving vaccine meningococcal a-c-y-w135 (d conj) vaccine (Menactra).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect meningococcal a-c-y-w135 (d conj) vaccine (dose, route, lot number and administration site: unknown) for prophylactic vaccination.  Reportedly patient was given expired dose of menactra on 22-Apr-2022, with no reported adverse event (expired product administered) (unknown latency) following the administration of meningococcal a-c-y-w135 (d conj) vaccine and asks should it be repeated?  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (was given expired dose of Menactra on 22APR2022, with no reported adverse event).  At time of reporting, the outcome was Unknown for the event was given expired dose of menactra on 22apr2022, with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: F
Vaccine: MNQ
Symptoms: Medication error, No adverse event, Wrong product administered
Clinical narrative: patient inadvertently received a dose of MENACTRA instead of the intended MEN B with no reported adverse event; Initial information received on 25-Apr-2022 regarding an unsolicited valid  non-serious case received from  other health professional.  This case involves a 16 years old female patient and it was reported that patient inadvertently received a dose of Menactra instead of the intended Men B with no reported adverse event,  while receiving vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 18-Apr-2017 she also received an unknown dose of the suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot number and expiry date: not reported) with an unknown batch number in unknown administration site. On 11-Mar-2022, the patient received a  second dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE( lot number and expiry date:  not reported) via unknown route in unknown administration site. On 19-Apr-2022 she also received a  0.5 ml dose of the same vaccine  (lot number: UJ268AA ; expiry date: 02-Apr-2023) via intramuscular route in the left deltoid for immunization.  On 19-APR-2022 the patient had visit for second dose of Men B and  inadvertently received a dose of Menactra instead of the intended Men B with no reported adverse event (wrong product administered) 5 years 1 day following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE.  Action taken : not applicable.  It was not reported if the patient received a corrective treatment for the event (patient inadvertently received a dose of MENACTRA instead of the intended MEN B with no reported adverse event).  Outcome: unknown  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: IPV
Symptoms: Medication error, No adverse event, Product storage error
Clinical narrative: vaccine bin not being placed back in the refrigerator after use with no reported adverse event; Initial information received on 26-Apr-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a patient of unknown demographics who reported vaccine bin of vaccine IPV (VERO) [IPOL] not being placed back in the refrigerator after use with no reported adverse event.   This case is linked to case 01078080(Companion Case for general vaccine). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date, the patient received a  dose of suspect IPV (VERO) (lot T1D481M, expiry:25-JUL-2022)  (formulation, strength, dose, lot number, expiration date, route of administration and administration site: unknown) as prophylactic vaccination (immunization).   On an unknown onset and latency, reportedly vaccine bin not being placed back in the refrigerator after use with no reported adverse event (product storage error). Max/low temperature reached: High of 72.0 F, Duration out of labelled range: 10 hours. The 1 punctured MDV IPOL was not suitable for use under the extended stability data.   Action taken: Not applicable.  Outcome: Unknown.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: IPV
Symptoms: Medication error, No adverse event, Product storage error
Clinical narrative: temperature excursion of 48 degree Fahrenheit for 48 hours due to a possible refrigerator malfunction with no reported adverse event; Initial information received on 26-Apr-2022 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves 5 unknown age and unknown gender pediatric patients who were administered with IPV (vero) [IPOL] after the vaccine was exposed to a temperature excursion of 48 degree Fahrenheit for 48 hours due to a possible refrigerator malfunction with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patients received a dose of suspect IPV (VERO) (lot T1E871M, expiry date: 10-Oct-2022; formulation, strength, dose, route not reported) for prophylactic immunization.  On an unknown date the patients were administered with IPV (vero) [IPOL] after the vaccine was exposed to a temperature excursion of 48 degree Fahrenheit for 48 hours due to a possible refrigerator malfunction with no reported adverse event (medication error).  It was reported "The Director called to report a temperature excursion involving one punctured IPOL and one sealed IPOL due to a possible refrigerator malfunction (not human error) and is requesting stability information. The condition was 48F for 48 hours. The unopened IPOL is supported by the extended stability data, however the punctured IPOL is not supported by the extended stability data. The caller confirmed that the punctured IPOL had been administered to 5 pediatric patients and will email back the safety information for those patients, as she did not have it available at the time of the call."  Action taken: not applicable.  Outcome: Unknown   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.25
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: No adverse event
Clinical narrative: pediatric patient given first dose of pentacel at the hospital at 2 months of age and given the 2nd dose at 3 months of age as mother did not disclose that first dose given at 2 months of age with no reported adverse event; Initial information received on 27-Apr-2022 regarding an unsolicited valid  non-serious case received from a other health professional via call center.  This case involves a 3 months old male patient who given first dose of pentacel at the hospital at 2 months of age and given the 2nd dose at 3 months of age as mother did not disclose that first dose given at 2 months of age with no reported adverse event while receiving vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL].     The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HEPATITIS B VACCINE (VACCINE, HEPATITIS B) for Immunisation; PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) for Immunisation; and ROTAVIRUS VACCINE LIVE ORAL 1V (ROTARIX) for Immunisation.  On 23-Dec-2021, the patient received dose: 2, 0.5ml total, dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot UJ577AAA exp: date: 10-Sep-2022 via intramuscular route in the left vastus lateralis for immunization.  On 23-DEC-2021 the patient given first dose of pentacel at the hospital at 2 months of age and given the 2nd dose at 3 months of age as mother did not disclose that first dose given at 2 months of age with no reported adverse event (product administered to patient of inappropriate age) following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE.  Action taken: was not applicable.  At time of reporting, the outcome was Unknown for the event.     This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.08
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Medication error, No adverse event, Product storage error
Clinical narrative: Patient only receiving the liquid component (DTAP-IPV) and not the ACTHIB component of the PENTACEL vaccine with no reported adverse event; Initial information was received on 28-Feb-2022 regarding an unsolicited valid non-serious case via call center received from physician.  This case involves a 1 months old male patient who experienced patient only receiving the liquid component (dtap-ipv) and not the acthib component of the pentacel vaccine with no reported adverse event while receiving vaccine diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine [PENTACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included pneumococcal vaccine CONJ 13V (CRM197) (PREVNAR 13) for Immunisation.   On 27-Apr-2022, the patient received 0ne dosage form of 0.5 ml of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine  (lot UJ62AAA, expiry- 7-dec-22) (strength; unknown) via intramuscular route in the left thigh for immunization.  On 27-APR-2022 the patient developed a non-serious patient only receiving the liquid component (dtap-ipv) and not the acthib component of the pentacel vaccine with no reported adverse event (product preparation error) (latency: same day) following the administration of diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine  Action Taken: not applicable.  At time of reporting, the outcome was Unknown for the event patient only receiving the liquid component (dtap-ipv) and not the acthib component of the pentacel vaccine with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 7.0
Sex: U
Vaccine: DTAP
Symptoms: Inappropriate schedule of product administration, Medication error, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 7 year old child received a dose of Daptacel for their second dose with no reported adverse event; 7 year old child received a dose of Daptacel for their second dose with no reported adverse event; Initial information received on 28-Apr-2022 regarding an unsolicited valid non-serious case received from other health professional.   This case involves a 7-year-old patient of unknown gender who received a dose of Diphtheria-15/Tetanus/5 Ac Pertussis Vaccine [Daptacel] for their second dose with no reported adverse event.     The patient's past medical history and family history were not provided.  The patient received no concomitant and additional medication.      On an unknown date, the patient received a dose of suspect diphtheria-15/tetanus/5 ac pertussis vaccine form:Suspension for injection, lot number not reported via unknown route in unknown administration site, drug structure dosage: na, drug interval dosage: once, drug treatment duration: na; for Immunisation.     On an unknown date Office manager reported that a 7-year-old child received a dose of daptacel for their second dose with no reported adverse event (inappropriate schedule of product administration) and (Inappropriate age at vaccine administration) (unknown latency). Caller asked if it would cause a problem. Caller declined to provide her address or information on the patient. Batch/lot number requested, not available at the time of call. Caller refused follow-up. This is reported as a potential Adverse Event because of a medication error (inappropriate use). To be evaluated by Reporter relationship : HCP Product used : Used First time product used : Yes Still using product : No.   Action taken was not applicable.  Outcome was Unknown.    This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 1.5
Sex: U
Vaccine: DTAP, TDAP
Symptoms: Medication error, No adverse event, Wrong product administered
Clinical narrative: the TDAP was given instead of the DTAP with no reported adverse event; Initial information received on 28-Apr-2022 regarding an unsolicited valid non-serious case from a other health professional.  This case involves a 18 months old patient with unknown gender to whom tdap was given instead of the dtap with no reported adverse event while receiving vaccines Diphtheria-15/Tetanus/5 Ac Pertussis Vaccine [Daptacel] and Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine [Adacel].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 28-Apr-2022, the patient received a  dose of suspect  Diphtheria-15/Tetanus/5 Ac Pertussis Vaccine [Daptacel]  suspension for injection and a dose of suspect Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine [Adacel] suspension for injection (dose, route, strength, lot number and expiry date: unknown) in unknown administration site for immunization.  On 28-APR-2022 the patient was given tdap instead of the dtap with no reported adverse event (wrong product administered) (latency: same day) following the administration of Diphtheria-15/Tetanus/5 Ac Pertussis Vaccine and Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine.  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray normal, Confusional state, Cough
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 03/12/2021.  2nd vaccine-04/09/2021.  3rd vaccine 11/02/2021.  87 y/o with PMHx of HTN, Diabetes, HLD, CP, TIA, CABG presents to ED with increased confusion, slurred speech, increased weakness/inability to ambulate, fever, cough and mild congestion.  Room air sat 100%.  CXR with no acute findings.  TIA workup and per ID-no particular tx indicated for Covid19.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Dysarthria, Gait inability, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 03/12/2021.  2nd vaccine-04/09/2021.  3rd vaccine 11/02/2021.  87 y/o with PMHx of HTN, Diabetes, HLD, CP, TIA, CABG presents to ED with increased confusion, slurred speech, increased weakness/inability to ambulate, fever, cough and mild congestion.  Room air sat 100%.  CXR with no acute findings.  TIA workup and per ID-no particular tx indicated for Covid19.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 03/12/2021.  2nd vaccine-04/09/2021.  3rd vaccine 11/02/2021.  87 y/o with PMHx of HTN, Diabetes, HLD, CP, TIA, CABG presents to ED with increased confusion, slurred speech, increased weakness/inability to ambulate, fever, cough and mild congestion.  Room air sat 100%.  CXR with no acute findings.  TIA workup and per ID-no particular tx indicated for Covid19.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Limb injury, Paraesthesia
Clinical narrative: Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy, Eyelid function disorder
Clinical narrative: Unable to close eye fully or move right side of face night 12/26 called primary care doc 12/27 told me to go to emergency room. Diagnosed with Bells Palsy and prescribed presnidone and antiviral treatment and eye drops/eye patch for sleep. Symptoms improved after one month.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Lethargy, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fainting / Unresponsive-Medium.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Breast swelling, Erythema, Fatigue, Headache, Oedema peripheral
Clinical narrative: Low grade fever to 100.8, left axilla swelling (3 inches by 7 inches) Left breast swelling, redness, and hot to touch. Area approx 5 inches by 9 inches from collar bone to lower breast. Fatigue, headache and body aches.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Skin warm
Clinical narrative: Low grade fever to 100.8, left axilla swelling (3 inches by 7 inches) Left breast swelling, redness, and hot to touch. Area approx 5 inches by 9 inches from collar bone to lower breast. Fatigue, headache and body aches.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Asthenia, COVID-19, Chest X-ray abnormal, Dyspnoea
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 02/25/2021.  2nd vaccine on 03/25/2021. 3rd vaccine on 11/26/2021. 86 y/o female presents to ED with c/o increasing SOB.  Pt had tested + for Covid19 on 04/29/2022 and was sent home on Paxlovid  After 2 doses, pt c/o generalized weakness, daughter took home pulse ox and heart rates 30's so brought to ED.  Pt endorses SOB, diaphoresis and epigastric pain.  Heart rate noted 30-40's, hypothermic, hypotensive, O2sats mid 80's, placed on 15L NRBM-admitted to ICU. CXR with trace right pleural effusion.  Started on IV steroids.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Hypotension, Hypothermia, Intensive care, Pleural effusion
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 02/25/2021.  2nd vaccine on 03/25/2021. 3rd vaccine on 11/26/2021. 86 y/o female presents to ED with c/o increasing SOB.  Pt had tested + for Covid19 on 04/29/2022 and was sent home on Paxlovid  After 2 doses, pt c/o generalized weakness, daughter took home pulse ox and heart rates 30's so brought to ED.  Pt endorses SOB, diaphoresis and epigastric pain.  Heart rate noted 30-40's, hypothermic, hypotensive, O2sats mid 80's, placed on 15L NRBM-admitted to ICU. CXR with trace right pleural effusion.  Started on IV steroids.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 02/25/2021.  2nd vaccine on 03/25/2021. 3rd vaccine on 11/26/2021. 86 y/o female presents to ED with c/o increasing SOB.  Pt had tested + for Covid19 on 04/29/2022 and was sent home on Paxlovid  After 2 doses, pt c/o generalized weakness, daughter took home pulse ox and heart rates 30's so brought to ED.  Pt endorses SOB, diaphoresis and epigastric pain.  Heart rate noted 30-40's, hypothermic, hypotensive, O2sats mid 80's, placed on 15L NRBM-admitted to ICU. CXR with trace right pleural effusion.  Started on IV steroids.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Pruritus, Rash
Clinical narrative: Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Itch Generalized-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild.
Age: 71.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Additional Details: PATIENT CAME INTO THE PHARMACY AFTER SYMPTOMS HAD RESOLVED.  HE CLAIMS HIS ARM SWELLED FROM THE ELBOW TO THE SHOULDER SO BADLY THAT HIS SKIN WAS STRETCHED.  IT WAS VERY TENDER, RED AND PAINFUL.  WHEN I ASKED HIM IF HE SOUGHT MEDICAL ATTENTION HE SAID NO.  HE FIGURED IT WOULD JUST GO AWAY  BY ITSELF . (WHICH IT DID)
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Rash, Rash pruritic
Clinical narrative: Two days after receiving the vaccine I started breaking out in a rash just on my right arm where I received the shot.  The rash continued down my arm to the wrist.  It only itches and continues to be uncomfortable to this day.  No other adverse effects.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal tenderness, COVID-19, Chills, Diarrhoea, Electrolyte imbalance
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 03/05/2021,  2nd vaccine on 03/26/2021.  78 y/o female presents to ED with c/o Sinus drainage, abdominal tenderness, congestion, chills, cough with clear sputum, and profound N/V/D.  Pt afebrile, room air sat 100%.  Pt with electrolyte imbalances being corrected.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Paranasal sinus hypersecretion, Productive cough, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 03/05/2021,  2nd vaccine on 03/26/2021.  78 y/o female presents to ED with c/o Sinus drainage, abdominal tenderness, congestion, chills, cough with clear sputum, and profound N/V/D.  Pt afebrile, room air sat 100%.  Pt with electrolyte imbalances being corrected.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccine breakthrough infection, Vomiting
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 03/05/2021,  2nd vaccine on 03/26/2021.  78 y/o female presents to ED with c/o Sinus drainage, abdominal tenderness, congestion, chills, cough with clear sputum, and profound N/V/D.  Pt afebrile, room air sat 100%.  Pt with electrolyte imbalances being corrected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Condition aggravated, Discomfort, Dysstasia, Joint stiffness
Clinical narrative: 2 weeks after receiving Covid 19 vaccine my knees rather quickly became very tight and very sore making it difficult to get up from a chair.  This condition has persisted with varying degrees of pain, discomfort, and impaired mobility.  Since 1/25/21, my osteo arthritis is exacerbated.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Osteoarthritis, Pain
Clinical narrative: 2 weeks after receiving Covid 19 vaccine my knees rather quickly became very tight and very sore making it difficult to get up from a chair.  This condition has persisted with varying degrees of pain, discomfort, and impaired mobility.  Since 1/25/21, my osteo arthritis is exacerbated.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Facial paralysis, Gait disturbance, Pain in extremity
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 08/02/2021.  2nd vaccine on 08/24/2021.  56 y/o male presents to ED after being found wandering around with Left facial droop and c/o left leg pain, trouble ambulating and weakness.  Pt lives at group home and has a PMHx of Autism, Bell's palsy, depression, anxiety, Hypothyroidism, AVF for renal dialysis and schozophrenia. No specific treatment for Covid19.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Patient elopement, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 08/02/2021.  2nd vaccine on 08/24/2021.  56 y/o male presents to ED after being found wandering around with Left facial droop and c/o left leg pain, trouble ambulating and weakness.  Pt lives at group home and has a PMHx of Autism, Bell's palsy, depression, anxiety, Hypothyroidism, AVF for renal dialysis and schozophrenia. No specific treatment for Covid19.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Back pain, Blood test, C-reactive protein increased, Exercise tolerance decreased
Clinical narrative: After the booster shot on 12/27/21 I had swollen lymph nodes under my left armpit.  (note the lot number on the 3rd shot was difficult to read as it was handwritten) Within a couple of weeks (Mid January 2022), tightness and soreness in lower back started.  I started to see a chiropractor but nothing helped with the tightness.   Beginning Mid February 2022, I began experiencing joint pain in my hips which eventually moved to my knees.  Severe pain as I have trouble walking and getting out of bed.  The soreness has  kept me from exercising which I actively participate at least 3 times a week.   I have never experienced anything like this so I began to wonder if I was getting arthritis.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Gait disturbance, Inflammatory marker increased, Loss of personal independence in daily activities, Lymphadenopathy, Mobility decreased
Clinical narrative: After the booster shot on 12/27/21 I had swollen lymph nodes under my left armpit.  (note the lot number on the 3rd shot was difficult to read as it was handwritten) Within a couple of weeks (Mid January 2022), tightness and soreness in lower back started.  I started to see a chiropractor but nothing helped with the tightness.   Beginning Mid February 2022, I began experiencing joint pain in my hips which eventually moved to my knees.  Severe pain as I have trouble walking and getting out of bed.  The soreness has  kept me from exercising which I actively participate at least 3 times a week.   I have never experienced anything like this so I began to wonder if I was getting arthritis.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Muscle tightness, Red blood cell sedimentation rate increased
Clinical narrative: After the booster shot on 12/27/21 I had swollen lymph nodes under my left armpit.  (note the lot number on the 3rd shot was difficult to read as it was handwritten) Within a couple of weeks (Mid January 2022), tightness and soreness in lower back started.  I started to see a chiropractor but nothing helped with the tightness.   Beginning Mid February 2022, I began experiencing joint pain in my hips which eventually moved to my knees.  Severe pain as I have trouble walking and getting out of bed.  The soreness has  kept me from exercising which I actively participate at least 3 times a week.   I have never experienced anything like this so I began to wonder if I was getting arthritis.
Age: 93.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid breakthrough case
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid breakthrough case
Age: 96.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Fatigue, Influenza A virus test
Clinical narrative: Breakthrough COVID infection leading to hospitalization. Symptoms beginning 4/30/22 including: cough, SOB, fatigue, and nausea.
Age: 96.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza B virus test, Nausea, SARS-CoV-2 test, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID infection leading to hospitalization. Symptoms beginning 4/30/22 including: cough, SOB, fatigue, and nausea.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Condition aggravated, Cough, Dyspnoea
Clinical narrative: 04/26/2022 I started with chills and headache. I took a home test that was negative. Then I had headache and fatigue. I took another test that night and it was positive. The next day I had congestion and fatigue. It got worse after that. I got really bad fatigue, shortness of breath, a headache, cough, aches and pains and sore throat. I still have fatigue and headache.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Oropharyngeal pain, Pain, Respiratory tract congestion
Clinical narrative: 04/26/2022 I started with chills and headache. I took a home test that was negative. Then I had headache and fatigue. I took another test that night and it was positive. The next day I had congestion and fatigue. It got worse after that. I got really bad fatigue, shortness of breath, a headache, cough, aches and pains and sore throat. I still have fatigue and headache.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: 04/26/2022 I started with chills and headache. I took a home test that was negative. Then I had headache and fatigue. I took another test that night and it was positive. The next day I had congestion and fatigue. It got worse after that. I got really bad fatigue, shortness of breath, a headache, cough, aches and pains and sore throat. I still have fatigue and headache.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Contracted Covid
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, Insomnia, Parosmia
Clinical narrative: Change of smell. Everything smells like glue or paste all the time now both in my home and while driving my car. It's difficult to fall asleep because the smell is so strong. I can't smell ordinary other odors now.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute myocardial infarction, COVID-19, Chest pain, Nausea, SARS-CoV-2 test positive
Clinical narrative: A male.  Admitted from the ER for chest pain, nausea & vomiting.  Patient had ST elevation myocardial infarction.  Hx. of CAD, Diabetes, hypertention & medical non-compliance.  Discharged home on 5/1/22.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: A male.  Admitted from the ER for chest pain, nausea & vomiting.  Patient had ST elevation myocardial infarction.  Hx. of CAD, Diabetes, hypertention & medical non-compliance.  Discharged home on 5/1/22.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, Myalgia, Pain in extremity, Ultrasound Doppler normal
Clinical narrative: 03/15/2021 I started having issues walking. Went to see a podiatrist. He did stuff with my shoes and it gradually got better over the summer. I woke up one morning and I could barely walk. The muscles in my legs were sore. I could hardly walk across the room. My knees also hurt. It got so bad so bad I was using a cane. I went to the doctor and he sent me to the ER to make sure I did not have a blood clot. I did not have a blood clot. About 3 weeks later, I had my 3rd shot. I was starting to get better and not having to use my cane. I still had soreness in my legs. I read about a person who had same type of problem. It has gotten better, am able to walk a couple of miles a day.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Walking aid user
Clinical narrative: 03/15/2021 I started having issues walking. Went to see a podiatrist. He did stuff with my shoes and it gradually got better over the summer. I woke up one morning and I could barely walk. The muscles in my legs were sore. I could hardly walk across the room. My knees also hurt. It got so bad so bad I was using a cane. I went to the doctor and he sent me to the ER to make sure I did not have a blood clot. I did not have a blood clot. About 3 weeks later, I had my 3rd shot. I was starting to get better and not having to use my cane. I still had soreness in my legs. I read about a person who had same type of problem. It has gotten better, am able to walk a couple of miles a day.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Full blood count abnormal, Laboratory test normal, Loss of consciousness, Pyrexia
Clinical narrative: High fever during the night, arose from bed to go to bathroom and passed out (synoptic event). Was taken to the hospital in locally.  Fractured arm in fall.  was discharged a few hours later with no further symptoms (fever, aches) other than fractured arm.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope, Upper limb fracture, White blood cell count increased
Clinical narrative: High fever during the night, arose from bed to go to bathroom and passed out (synoptic event). Was taken to the hospital in locally.  Fractured arm in fall.  was discharged a few hours later with no further symptoms (fever, aches) other than fractured arm.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Mobility decreased, Pain, Pyrexia
Clinical narrative: On March 29, 2022 at 11:30PM, I started to have chills, fevers, and my whole body started to hurt. I took some Tylenol that night and stayed in bed because I was shaking so bad. The next day I took an at home test and tested positive. I then, called Dr.'s office the next morning and spoke with her nurse who related all of my symptoms to Dr. I was told to stay in the house for 5 days until my fever broke. I wasn't offered any medicine.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Tremor
Clinical narrative: On March 29, 2022 at 11:30PM, I started to have chills, fevers, and my whole body started to hurt. I took some Tylenol that night and stayed in bed because I was shaking so bad. The next day I took an at home test and tested positive. I then, called Dr.'s office the next morning and spoke with her nurse who related all of my symptoms to Dr. I was told to stay in the house for 5 days until my fever broke. I wasn't offered any medicine.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Ear disorder
Clinical narrative: Damaged eardrum, possibly ruptured while blowing nose.
Age: 5.0
Sex: F
Vaccine: IPV
Symptoms: Product storage error
Clinical narrative: Vaccine given to patient after a temperature excursion and the dose needs to be repeated.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Aphasia, COVID-19, Cardiac failure, Femur fracture, Hyperlipidaemia
Clinical narrative: Transfer from Facility for AMS.  History was obtained from patient's nephew and Facility.  Patient was recently discharged from Facility on 04/20/2022 status post ORIF of right femur.  Per Facility, patient was sent to Facility ED due to AMS, saying she was incoherent, not speaking, slumped over in bed, and not following commands. They thought she may have been having a stroke.  Per patient's nephew, patient likely has had dementia for several years, but has no formal diagnosis.  He states that her baseline mentation is alert and oriented to self, waxes and wanes, and can only carry simple conversations at times.  Nephew states she was at her baseline mentation upon discharge, and was indeed somewhat altered upon arrival to the hospital. Discharge Diagnosis: 1:Altered mental status; 2:Left upper lobe pneumonia; 3:UTI (urinary tract infection), bacterial;;; (HFpEF) heart failure with preserved ejection fraction; Compression fracture of L4 vertebra; Hyperlipidemia; Hypertension; Hypothyroidism in adult; Metabolic encephalopathy; Osteoarthritis of knee; Rheumatoid arthritis.  Discharged on 5/1/22.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypertension, Hypothyroidism, Hypotonia, Incoherent, Mental status changes
Clinical narrative: Transfer from Facility for AMS.  History was obtained from patient's nephew and Facility.  Patient was recently discharged from Facility on 04/20/2022 status post ORIF of right femur.  Per Facility, patient was sent to Facility ED due to AMS, saying she was incoherent, not speaking, slumped over in bed, and not following commands. They thought she may have been having a stroke.  Per patient's nephew, patient likely has had dementia for several years, but has no formal diagnosis.  He states that her baseline mentation is alert and oriented to self, waxes and wanes, and can only carry simple conversations at times.  Nephew states she was at her baseline mentation upon discharge, and was indeed somewhat altered upon arrival to the hospital. Discharge Diagnosis: 1:Altered mental status; 2:Left upper lobe pneumonia; 3:UTI (urinary tract infection), bacterial;;; (HFpEF) heart failure with preserved ejection fraction; Compression fracture of L4 vertebra; Hyperlipidemia; Hypertension; Hypothyroidism in adult; Metabolic encephalopathy; Osteoarthritis of knee; Rheumatoid arthritis.  Discharged on 5/1/22.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Metabolic encephalopathy, Neurological symptom, Open reduction of fracture, Osteoarthritis, Pneumonia
Clinical narrative: Transfer from Facility for AMS.  History was obtained from patient's nephew and Facility.  Patient was recently discharged from Facility on 04/20/2022 status post ORIF of right femur.  Per Facility, patient was sent to Facility ED due to AMS, saying she was incoherent, not speaking, slumped over in bed, and not following commands. They thought she may have been having a stroke.  Per patient's nephew, patient likely has had dementia for several years, but has no formal diagnosis.  He states that her baseline mentation is alert and oriented to self, waxes and wanes, and can only carry simple conversations at times.  Nephew states she was at her baseline mentation upon discharge, and was indeed somewhat altered upon arrival to the hospital. Discharge Diagnosis: 1:Altered mental status; 2:Left upper lobe pneumonia; 3:UTI (urinary tract infection), bacterial;;; (HFpEF) heart failure with preserved ejection fraction; Compression fracture of L4 vertebra; Hyperlipidemia; Hypertension; Hypothyroidism in adult; Metabolic encephalopathy; Osteoarthritis of knee; Rheumatoid arthritis.  Discharged on 5/1/22.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Rheumatoid arthritis, SARS-CoV-2 test positive, Spinal compression fracture, Urinary tract infection bacterial
Clinical narrative: Transfer from Facility for AMS.  History was obtained from patient's nephew and Facility.  Patient was recently discharged from Facility on 04/20/2022 status post ORIF of right femur.  Per Facility, patient was sent to Facility ED due to AMS, saying she was incoherent, not speaking, slumped over in bed, and not following commands. They thought she may have been having a stroke.  Per patient's nephew, patient likely has had dementia for several years, but has no formal diagnosis.  He states that her baseline mentation is alert and oriented to self, waxes and wanes, and can only carry simple conversations at times.  Nephew states she was at her baseline mentation upon discharge, and was indeed somewhat altered upon arrival to the hospital. Discharge Diagnosis: 1:Altered mental status; 2:Left upper lobe pneumonia; 3:UTI (urinary tract infection), bacterial;;; (HFpEF) heart failure with preserved ejection fraction; Compression fracture of L4 vertebra; Hyperlipidemia; Hypertension; Hypothyroidism in adult; Metabolic encephalopathy; Osteoarthritis of knee; Rheumatoid arthritis.  Discharged on 5/1/22.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Headache, Pain
Clinical narrative: Chills, shivering, headache, body ache
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Breast mass, Mammogram, Menstruation irregular, Sexually transmitted disease test, Ultrasound scan
Clinical narrative: I had bleeding between my cycle, so basically 2 cycles a month. I also had a breast lump. These symptoms also continued after the booster dose 3.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dyspnoea
Clinical narrative: increased weakness and shortness of breath in post polio patient
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea, Feeling abnormal, Laboratory test normal, Menstruation irregular, Suicidal ideation
Clinical narrative: I got my booster on 12/15/2021, around 12/16/2021 I got a breakthrough period, I went to the ER on 12/18/21 because my period was freaking me out. I do not have periods. They said it was natural. It was triggering suicidal thoughts.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Injection site induration, Injection site reaction, Injection site swelling, Injection site warmth, Pain in extremity
Clinical narrative: she had no reaction after the 1st dose of Men B vaccine. After the 2nd dose continued now for 2 days later, the injection site is the size of a small pancake, blotchy, feverish and hard. Her arm aches all the way down. Has taken Tylenol, semi-phased it.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Rash macular
Clinical narrative: she had no reaction after the 1st dose of Men B vaccine. After the 2nd dose continued now for 2 days later, the injection site is the size of a small pancake, blotchy, feverish and hard. Her arm aches all the way down. Has taken Tylenol, semi-phased it.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Headache, Pyrexia
Clinical narrative: I started getting symptoms of fever, chills, headache, and sneezing. I had a positive at home COVID-19 test and then went to urgent care and received a positive test as well. I got a prescription of Paxlovid. I now have a cough, worse chills, and runny nose.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive, Sneezing
Clinical narrative: I started getting symptoms of fever, chills, headache, and sneezing. I had a positive at home COVID-19 test and then went to urgent care and received a positive test as well. I got a prescription of Paxlovid. I now have a cough, worse chills, and runny nose.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Herpes zoster, Pain, Rash erythematous, Scab
Clinical narrative: I believe I'm being asked to fill this form out because I reported getting Shingles (~5 months after my last COVID vaccination) on my v-safe check-in questionnaire. The Shingles symptoms started with pain on my right side, wrapping around my abdomen, and a few days later the red rash appeared. I had a video visit with a Dr. who prescribed an anti-viral medication that I began approx. 6 days after the pain started. The medication seemed to help slow the spread, but discomfort persisted for 3-4 weeks until the rash scabbed over and symptoms decreased.